Evogliptin
Drug timelines are a Plus or Pro feature.
16 regulatory and trial events tracked for Evogliptin, covering 2014-12-02 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS) [Phase 2, Phase 3]